tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 241 are a BUY (84.56%), 36 are a HOLD (12.63%), 8 are a SELL (2.81%).
Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 51.5% that have a potential upside of 28.65% achieved within 196 days.
Mark Massaro’s has documented 558 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 18-Dec-2024.
Analyst best performing recommendations are on TKNO (ALPHA TEKNOVA).
The best stock recommendation documented was for GHDX (GENOMIC HEALTH) at 11/7/2018. The price target of $82 was fulfilled within 2 days with a profit of $8.18 (9.07%) receiving and performance score of 45.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$9
$1.33 (17.34%)
$7.5
10 days ago
(21-Mar-2025)
3/5 (60%)
$0.6 (7.14%)
144
Buy
$11
$3.33 (43.42%)
$7
1 months 11 days ago
(20-Feb-2025)
7/12 (58.33%)
$2.63 (31.42%)
100
Buy
$9
$1.33 (17.34%)
$8
3 months 13 days ago
(18-Dec-2024)
4/8 (50%)
$3.03 (50.75%)
101
Buy
$6
$-1.67 (-21.77%)
$8
7 months 29 days ago
(02-Aug-2024)
2/2 (100%)
$1.7 (39.53%)
222
Hold
$10
$2.33 (30.38%)
$13
1 years 5 months 7 days ago
(24-Oct-2023)
1/6 (16.67%)
$5.31 (113.22%)
5
Which stock is Mark Massaro is most bullish on?
Which stock is Mark Massaro is most reserved on?
What Year was the first public recommendation made by Mark Massaro?
